 |
 |
| FDA Warns Consumers on Dangerous Products Promoted on the Internet |
 |
 |
|
|
United States |
|
FDA is warning consumers not to purchase certain unapproved products that pose significant, possibly life-threatening health risks. The products in question, which are offered for sale on the Internet, are home abortion kits and female self-sterilization kits.
The abortion kit inaccurately touts itself as a "complete kit for early pregnancy termination without surgery...scientifically proved safe and unrisky." The kit provides a combination of drugs that are not approved by FDA to terminate pregnancy. The agency conducted a health hazard assessment of this product and concluded that using the kit without a physician's supervision could cause heavy vaginal bleeding and even death. Birth defects also can result if a pregnancy is carried to term after taking these drugs.
The self sterilization kit claims to use a method similar to inserting an IUD and to have a much lower risk than that associated with surgical sterilization. The kit uses pellets of quinacrine hydrochloride, an unapproved drug, which can cause ectopic pregnancy, abnormal pregnancies, and permanent damage to a woman's reproductive organs.
FDA urges consumers not to purchase or use these or similar products promoted via Internet or any other media. The Federal Food, Drug, and Cosmetic Act prohibits the sale and promotion of unapproved medical products. The agency is continuing to investigate and monitor these products.
|
 |
|
|
|
| Related Site |
|
|
Counselling Aspects of Pregnancy Termination with Mifegyne : Mifegyne® does not essentially change the counselling in the conflict case of an unwanted pregnancy. The previous counselling only has to be supplemented when it comes to the specific implementation. Here, good information and counselling with sufficient time are necessary, so that each woman can arrive at the best decision regarding the method for her. This and sympathetic counselling during the treatment form the basis for a good course of the
Medical Abortions with Methotrexate and Misoprostol : Some clinics offer non-surgical medical abortions using Methotrexate and Misoprostol in the early stages of pregnancy (usually before 7-8 weeks LMP). These drugs are not approved specifically for this purpose by the FDA, but have been used successfully by many doctors.
The Abortion Pill: Mifepristone and Misoprostol for Early Abortion : The Abortion Pill (brand name Mifeprex) is a form of early abortion caused by the combination of two medications, mifepristone and misoprostol. Also known as RU486, mifepristone has been used safely in Europe for many years. The Abortion Pill is an early abortion option for women who are 8 weeks pregnant or less. During the first appointment at the clinic you receive the mifepristone pill to take orally. Then 24 to 72 hours later, in the privacy
Abortion Pill: Non-Surgical / Medical Abortions : Non-surgical / medical abortion or abortion by pill is a relatively new method of termination of pregnancy for early pregnancies (below 7-9 weeks of pregnancy from the first day of the last menstrual period, confirmed by ultrasound dating). Even prior to RU-486 or Mifeprex, our OB/GYN physicians have had years of valuable experience in providing non-surgical abortions. In this method, medications are used to cause the pregnancy to stop growing an
Coalition on Abortion/Breast Cancer : In 1986, government scientists wrote a letter to the British journal Lancet and acknowledged that abortion is a cause of breast cancer. They wrote, "Induced abortion before first term pregnancy increases the risk of breast cancer."
As of 2006, eight medical organizations recognize that abortion raises a woman's risk for breast cancer, independently of the risk of delaying the birth of a first child (a secondary effect that all experts alrea
Methotrexate and Misoprostol to Terminate Early Pregnancy : Background Although medical termination of pregnancy is available in Europe and China as an alternative to surgical termination, political and social factors have blocked medical approaches to pregnancy termination in the United States. Methotrexate, which is toxic to trophoblastic tissue, has been used safely to treat unruptured ectopic pregnancies. This report describes the use of a single low dose of methotrexate followed by intravaginal misop
Non-Surgical Abortions with Methotrexate : Beginning in September of 1995, BSS International began offering non-surgical abortion with Methotrexate/Misoprostol as an alternative to traditional surgery in early pregnancy. Currently we restrict this procedure to pregnancies seven weeks or less as determined by transvaginal ultrasound. This relatively early cut-off was based upon published reports which were later confirmed by our own experience indicating that beyond this stage the failure
1 to 9 months - Abortion in India : Overview of procedures offered in India and laws respecting pregnancy termination.
Surgical Abortion : Brief overview of the early surgical abortion procedure, including advantages and disadvantages. From Emory University Department of Gynecology and Obstretrics.
Sister Zeus: Preventing and Ending Pregnancy : Provides how-to information and discusses risks of herbal abortions.
|
|
|
 |
 |
 |
Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval for Tykerb (lapatinib) to include
postmenopausal women with hormone- and HER2-positive advanced breast
cancer who require hormone therapy. |
|
U.S. Kids Using Media Almost 8 Hours a Day (HealthDay)
HealthDay - WEDNESDAY, Jan. 20 (HealthDay News) -- The amount of time
American children and teens spend watching TV, playing video games or
surfing the Internet has increased dramatically, to almost eight hours a
day, a new report finds. |
|
Report: UK drinking culture strains health system (AP)
AP - Just as Britons brew black coffee to cope with holiday hangovers, they are also digesting a new report that warns the country's notorious drinking culture is putting an unacceptable strain on hospitals and medical staff. |
|
It's Not a Hangover, It's an Allergic Reaction (HealthDay)
HealthDay - FRIDAY, Jan. 1 (HealthDay News) -- For people with allergies and
asthma, toasting the New Year could result in more than a hangover; it
could also set off a variety of unpleasant reactions, warns an
organization of allergists. |
|
|
 |
